PFM
GILD icon

Potomac Fund Management’s Gilead Sciences GILD Stock Holding History

Potomac Fund Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Buy
16,241
+31
+0.2% +$4.08K 0.05% 34
2026
Q1 		$2.26M Sell
16,210
-912
-5% -$128K 0.08% 29
2025
Q4 		$2.1M Sell
17,122
-1,817
-10% -$221K 0.08% 32
2025
Q3 		$2.1M Sell
18,939
-553
-3% -$62.9K 0.09% 33
2025
Q2 		$2.14M Sell
19,492
-964
-5% -$103K 0.12% 29
2025
Q1 		$2.13M Buy
20,456
+1,102
+6% +$114K 0.94% 10
2024
Q4 		$1.79M Buy
+19,354
New +$1.74M 0.1% 29

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Potomac Fund Management's GILD Position: Q2 2026 in Review

Potomac Fund Management increased its Gilead Sciences (GILD) stake by 0.19% in Q2 2026, buying an estimated $4.08K and bringing the position to 16,241 shares worth $2.05M. The position accounts for 0.05% of the portfolio, ranked #34.

Potomac Fund Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.26M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Potomac Fund Management held 16,241 shares of Gilead Sciences worth $2.05M as of Q2 2026.
  • Potomac Fund Management bought 31 Gilead Sciences shares in Q2 2026, an estimated $4.08K.
  • Gilead Sciences made up 0.05% of Potomac Fund Management's portfolio in Q2 2026, its #34 holding.
  • Potomac Fund Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Potomac Fund Management's Gilead Sciences position peaked at $2.26M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Potomac Fund Management's 13F filing for Q2 2026, filed 13 Aug 2026.